Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × alirocumab × Clear all

Phase

Status

Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 28 Magnetic Resonance Spectroscopy 20 Cyclophosphamide 17 Biopsy 16 Vincristine 9 Nivolumab 9 Doxorubicin 9 Cisplatin 9 Prednisone 8 Paclitaxel 8 Bevacizumab 8 Gemcitabine 7 pembrolizumab 6 Rituximab 6 Etoposide 6 Drug Therapy 6 Docetaxel 6 Carboplatin 6 Radiotherapy 5 Radiosurgery 5 Fluorouracil 5 Capecitabine 5 venetoclax 4 prednylidene 4 fludarabine 4 durvalumab 4 deltacortene 4 atezolizumab 4 S 1 (combination) 4 Radiation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Duke University

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡